Antibiotics 2013, 2(3), 339-351; doi:10.3390/antibiotics2030339
Review

Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia

1 College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Ave., Suite 203, Memphis, TN 38632, USA 2 Harrison School of Pharmacy, Auburn University, 1321 Walker Building, Auburn, AL 36849, USA
* Author to whom correspondence should be addressed.
Received: 2 April 2013; in revised form: 15 June 2013 / Accepted: 18 June 2013 / Published: 4 July 2013
(This article belongs to the Special Issue Antibiotics and Respiratory Tract Infections)
PDF Full-text Download PDF Full-Text [353 KB, uploaded 4 July 2013 12:12 CEST]
Abstract: Ventilator-associated pneumonia (VAP) is the most common infectious complication in the intensive care unit. It can increase duration of mechanical ventilation, length of stay, costs, and mortality. Improvements in the administration of empirical antibiotic therapy have potential to reduce the complications of VAP. This review will discuss the current data addressing empirical antibiotic therapy and the effect on mortality in patients with VAP. It will also address factors that could improve the administration of empirical antibiotics and directions for future research.
Keywords: empirical; antibiotic; ventilator-associated pneumonia

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Swanson, J.M.; Wells, D.L. Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia. Antibiotics 2013, 2, 339-351.

AMA Style

Swanson JM, Wells DL. Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia. Antibiotics. 2013; 2(3):339-351.

Chicago/Turabian Style

Swanson, Joseph M.; Wells, Diana L. 2013. "Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia." Antibiotics 2, no. 3: 339-351.

Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert